MREO - Balance Sheet - Mereo BioPharma Group plc

Current Liabilities	13.8 M
Accounts Payable	2.44 M
Short-Term Debt	5.54 M
Other Current Liabilities	5.87 M
Non-Current Liabilities	1.57 M
Long-Term Debt	0
Other Non-Current Liabilities	1.57 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018	Dec-2017	Dec-2016	Dec-2015
ASSETS
Cash & Cash Equivalents	69.8	57.4	56.3	94.3	23.5	16.3	25.0	50.0	53.6	79.7
Short Term Investments	0	0	51.1	0.6	0.5	0.5	2.5	2.5	0	0
Receivables	0	3.7	2.7	1.4	1.0	0	0	0	0	0
Inventory	0	0	(2.7)	(1.8)	(4.6)	(12.0)	(0.3)	(2.5)	(53.9)	0
Other Current Assets	1.7	2.6	4.3	5.0	1.6	2.1	7.0	10.6	7.2	1.6
Total Current Assets	74.8	63.8	62.1	99.3	29.7	30.4	34.5	63.2	60.8	81.3
PP&E	1.0	1.6	1.8	2.5	1.6	11.6	0.1	0.2	0.2	0.2
Intangible Assets	0.6	1.1	24.1	24.6	31.6	44.5	32.6	33.0	25.8	25.8
Goodwill	0	0	0	0	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0	0	0	0	0
Other Long Term Assets	0	0	(25.9)	(27.1)	(33.2)	(56.0)	0	0	0	0
Other Assets	0	0	0	0	0	0	0	0	0	0
Total Assets	76.4	66.5	88.1	126.4	62.9	86.4	67.3	96.3	86.8	107.3
LIABILITIES
Accounts Payable	2.4	2.3	3.5	2.3	2.9	5.9	5.6	2.6	1.2	1.1
Short Term Debt	5.5	0.7	11.6	0.6	0.6	17.7	6.8	1.9	0	0
Other Current Liabilities	5.1	5.8	9.4	7.9	8.0	6.1	3.6	8.3	1.9	4.8
Total Current Liabilities	13.8	9.5	24.7	12.5	8.6	29.9	16.2	9.6	3.2	2.8
Long Term Debt	0	5.3	1.5	1.8	17.3	19.3	14.6	18.8	3.1	2.8
Deferred Tax Income	0	0	0	0	0	0	0	0	0	0
Other Liabilities	1.6	1.2	54 K	36.0	60.0	24.3	3.7	5.4	1.2	0.1
Total Liabilities	15.4	16.0	26.2	38.4	77.9	46.2	34.5	33.9	7.5	5.8
EQUITY
Common Stock	3.1	2.8	1.9	1.8	1.0	0.3	0.2	0.2	0.2	59.2 K
Retained Earnings	(462.9)	(419.6)	(331.2)	(297.0)	(309.7)	(146.1)	(111.2)	(79.3)	(33.6)	(12.2)
Other Accumulative Comprehensive Income/Loss	(18.8)	(17.5)	137.9	136.9	133.2	47.3	25.6	23.4	12.7	0
Total Equity	61.0	50.5	61.9	88.0	(15.0)	40.3	32.8	62.5	79.3	101.5
Total Liabilities and Equity	76.4	66.5	88.1	126.4	62.9	86.4	67.3	96.3	86.8	107.3
SHARES OUTSTANDING
Common Shares Outstanding	147.9	131.9	120.6	116.7	67.8	17.9	14.2	13.8	9.0

Free